Bayo, Mariflor M.
HRN: 23-72-33 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/21/2023
CEFTRIAXONE 1G (VIAL)
09/21/2023
09/27/2023
IV
2g
Q24
Acute Pyelonephritis; R/O Typhoid Fever
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes